Enhanced expression and activity of DNA polymerase β in human ovarian tumor cells: impact on sensitivity towards antitumor agents
- 27 September 2001
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 20 (43), 6181-6187
- https://doi.org/10.1038/sj.onc.1204743
Abstract
DNA polymerase β, one of the most inaccurate DNA synthesizing enzymes, has been shown to confer genetic instability when up-regulated in cells, a situation found in several human cancers. Here, we demonstrated that enhanced activity and expression of this enzyme occur in the human ovarian tumor 2008/C13*5.25 cells, which are resistant to the antitumor agent cisplatin and hypersensitive to 6-thioguanine. We found that translesion synthesis across platinated DNA crosslinks as well as increased incorporation into DNA of 6-thioguanine took place in the 2008/C13*5.25 cells compared to the parental 2008 cells. Such features being molecular signatures of DNA polymerase β, these findings suggest that deregulation of its expression in cancer cells may contribute to the modulation of the response to antitumor treatments and therefore to tumor progression.This publication has 25 references indexed in Scilit:
- Nucleotide excision repair DNA synthesis by excess DNA polymerase β: a potential source of genetic instability in cancer cellsThe FASEB Journal, 2000
- Overexpression of DNA polymerase β: a genomic instability enhancer processThe FASEB Journal, 1999
- Mutator phenotype of BCR – ABL transfected Ba/F3 cell lines and its association with enhanced expression of DNA polymerase βOncogene, 1999
- Overexpression of DNA polymerase β in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugsProceedings of the National Academy of Sciences of the United States of America, 1998
- Elevated Expression of DNA Polymerase β Gene in Glioma Cell Lines with Acquired Resistance to 1-(4-Amino-2-methyl- 5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosoureaBiochemical and Biophysical Research Communications, 1996
- Bypass Replication of the Cisplatin-d(GpG) Lesion by Calf Thymus DNA Polymerase β and Human Immunodeficiency Virus Type I Reverse Transcriptase Is Highly MutagenicOnline Journal of Public Health Informatics, 1996
- Transplacental Carcinogenesis by Cisplatin in F344/NCR Rats: Promotion of Kidney Tumors by Postnatal Administration of Sodium BarbitalToxicology and Applied Pharmacology, 1995
- Rapid Emergence of Acquired cis-Diamminedichloroplatinum(II) Resistance in an In Vivo Model of Human Ovarian CarcinomaCancer Communications, 1990
- Repair synthesis by human cell extracts in DNA damaged bycis- andtrans-diamminedichloroplatinum(II)Nucleic Acids Research, 1989
- Clinical pharmacology of the 6-thiopurinesCancer Treatment Reviews, 1979